Nifty
:
22795.90
Sensex
:
75311.06
-117.25 (-0.51%)
-424.90 (-0.56%)
Nifty
Sensex
:
:
22795.90
75311.06
-117.25 (-0.51%)
-424.90 (-0.56%)

Apollo Hospitals Enterprise Ltd.

Hospital & Healthcare Services

Rating :
N/A

BSE: 508869 | NSE: APOLLOHOSP

NSE BSE
6874.25
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  6837.40
  •  6925.00
  •  6785.55
  •  6944.65
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  334197
  •  22945.04
  •  7545.35
  •  5693.20

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 90,853.93
  • 69.35
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 93,492.13
  • 0.25%
  • 11.55

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 29.33%
  • 0.28%
  • 3.66%
  • FII
  • DII
  • Others
  • 45.27%
  • 19.02%
  • 2.44%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.92
  • 11.13
  • 9.14

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.52
  • 8.62
  • 1.81

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.29
  • 13.97
  • -5.65

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 87.52
  • 88.23
  • 87.44

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.03
  • 11.27
  • 11.93

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 29.57
  • 33.30
  • 33.60

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
62.5
100.92
135.07
173.69
P/E Ratio
111.72
69.19
51.7
40.2
Revenue
19059
22072
25717
30263
EBITDA
2391
3108
3863
4699
Net Income
899
1457
1948
2503
ROA
5.8
9
10.4
11.9
P/Bk Ratio
14.48
12.33
10.21
8.31
ROE
13.68
18.89
20.85
21.76
FCFF
519.8
1013.89
1465.37
2190.17
FCFF Yield
0.49
0.96
1.38
2.07

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
5,526.90
4,850.60
13.94%
5,589.30
4,846.90
15.32%
5,085.60
4,417.80
15.12%
4,943.90
4,302.20
14.92%
Expenses
4,765.40
4,236.90
12.47%
4,773.80
4,219.40
13.14%
4,410.50
3,908.80
12.84%
4,303.40
3,814.10
12.83%
EBITDA
761.50
613.70
24.08%
815.50
627.50
29.96%
675.10
509.00
32.63%
640.50
488.10
31.22%
EBIDTM
13.78%
12.65%
14.59%
12.95%
13.27%
11.52%
12.96%
11.35%
Other Income
63.80
27.80
129.50%
38.20
22.20
72.07%
37.20
28.20
31.91%
28.10
16.40
71.34%
Interest
109.80
112.60
-2.49%
117.50
111.30
5.57%
116.40
106.20
9.60%
119.30
95.40
25.05%
Depreciation
184.60
167.00
10.54%
184.50
163.40
12.91%
177.40
166.90
6.29%
189.70
159.10
19.23%
PBT
530.90
361.90
46.70%
551.70
376.90
46.38%
418.50
264.10
58.46%
359.60
250.00
43.84%
Tax
156.80
108.90
43.99%
161.70
130.20
24.19%
114.50
96.60
18.53%
109.80
108.00
1.67%
PAT
374.10
253.00
47.87%
390.00
246.70
58.09%
304.00
167.50
81.49%
249.80
142.00
75.92%
PATM
6.77%
5.22%
6.98%
5.09%
5.98%
3.79%
5.05%
3.30%
EPS
25.89
17.06
51.76%
26.34
16.20
62.59%
21.23
11.59
83.18%
17.65
10.05
75.62%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
21,145.70
19,059.20
16,612.50
14,662.60
10,560.00
11,246.80
9,617.40
8,243.47
7,255.70
6,214.65
5,178.45
Net Sales Growth
14.81%
14.73%
13.30%
38.85%
-6.11%
16.94%
16.67%
13.61%
16.75%
20.01%
 
Cost Of Goods Sold
10,927.10
9,805.50
8,574.30
7,573.50
5,684.20
5,498.90
4,660.90
4,032.66
3,598.88
3,054.74
2,581.20
Gross Profit
10,218.60
9,253.70
8,038.20
7,089.10
4,875.80
5,747.90
4,956.50
4,210.81
3,656.83
3,159.91
2,597.26
GP Margin
48.32%
48.55%
48.39%
48.35%
46.17%
51.11%
51.54%
51.08%
50.40%
50.85%
50.16%
Total Expenditure
18,253.10
16,668.50
14,562.90
12,477.50
9,426.90
9,665.80
8,554.70
7,452.09
6,548.95
5,534.38
4,443.78
Power & Fuel Cost
-
247.20
217.50
193.70
169.70
213.00
183.80
166.68
127.89
122.80
93.98
% Of Sales
-
1.30%
1.31%
1.32%
1.61%
1.89%
1.91%
2.02%
1.76%
1.98%
1.81%
Employee Cost
-
2,493.70
2,176.70
1,786.50
1,601.00
1,852.90
1,598.20
1,404.39
1,196.50
1,023.55
860.02
% Of Sales
-
13.08%
13.10%
12.18%
15.16%
16.47%
16.62%
17.04%
16.49%
16.47%
16.61%
Manufacturing Exp.
-
2,290.90
1,981.00
1,800.80
492.60
504.30
419.80
433.58
414.16
387.28
296.08
% Of Sales
-
12.02%
11.92%
12.28%
4.66%
4.48%
4.37%
5.26%
5.71%
6.23%
5.72%
General & Admin Exp.
-
1,707.10
1,494.40
1,009.10
1,253.80
1,366.30
1,551.20
1,291.65
1,116.65
868.33
563.51
% Of Sales
-
8.96%
9.00%
6.88%
11.87%
12.15%
16.13%
15.67%
15.39%
13.97%
10.88%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Miscellaneous Exp.
-
124.10
119.00
113.90
225.60
230.40
140.80
123.13
94.88
77.67
0.00
% Of Sales
-
0.65%
0.72%
0.78%
2.14%
2.05%
1.46%
1.49%
1.31%
1.25%
0.95%
EBITDA
2,892.60
2,390.70
2,049.60
2,185.10
1,133.10
1,581.00
1,062.70
791.38
706.75
680.27
734.67
EBITDA Margin
13.68%
12.54%
12.34%
14.90%
10.73%
14.06%
11.05%
9.60%
9.74%
10.95%
14.19%
Other Income
167.30
106.30
90.30
78.20
49.10
33.20
32.40
33.95
44.33
52.54
36.75
Interest
463.00
449.40
380.80
378.60
449.20
532.80
327.00
295.07
257.35
180.02
117.85
Depreciation
736.20
687.00
615.40
600.70
573.10
619.70
395.50
359.03
314.04
263.83
211.65
PBT
1,860.70
1,360.60
1,143.70
1,284.00
159.90
461.70
372.60
171.24
179.69
288.95
441.92
Tax
542.80
445.50
256.20
477.00
84.70
225.10
173.40
111.91
90.96
96.90
130.00
Tax Rate
29.17%
32.70%
22.40%
30.23%
38.38%
34.11%
46.54%
65.35%
50.62%
31.78%
28.55%
PAT
1,317.90
880.60
862.30
1,048.30
149.60
458.00
235.00
117.19
178.60
209.14
330.55
PAT before Minority Interest
1,279.00
917.00
887.50
1,101.10
136.00
434.90
199.20
59.33
88.73
207.99
325.41
Minority Interest
-38.90
-36.40
-25.20
-52.80
13.60
23.10
35.80
57.86
89.87
1.15
5.14
PAT Margin
6.23%
4.62%
5.19%
7.15%
1.42%
4.07%
2.44%
1.42%
2.46%
3.37%
6.38%
PAT Growth
62.86%
2.12%
-17.74%
600.74%
-67.34%
94.89%
100.53%
-34.38%
-14.60%
-36.73%
 
EPS
91.65
61.24
59.97
72.90
10.40
31.85
16.34
8.15
12.42
14.54
22.99

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
6,935.40
6,197.40
5,623.30
4,602.50
3,339.10
3,333.50
3,251.51
3,313.20
3,331.13
3,171.33
Share Capital
71.90
71.90
71.90
71.90
69.60
69.60
69.56
73.01
69.56
69.56
Total Reserves
6,691.10
6,040.60
5,542.50
4,524.30
3,266.50
3,261.10
3,180.05
3,238.91
3,260.64
3,100.63
Non-Current Liabilities
6,808.90
6,225.50
6,242.00
5,590.10
6,482.70
4,613.00
4,423.17
4,398.65
2,700.91
2,138.49
Secured Loans
2,231.40
1,923.70
2,408.20
2,466.00
2,852.00
2,868.70
2,728.43
2,477.64
2,303.08
1,563.22
Unsecured Loans
4.20
13.90
19.00
7.40
0.00
83.40
195.37
475.74
146.70
164.83
Long Term Provisions
2,124.90
1,723.40
1,341.60
1,061.00
1,011.20
883.00
784.96
701.39
3.27
3.45
Current Liabilities
4,664.50
3,324.90
2,434.30
2,038.00
2,337.30
1,955.40
1,567.23
963.36
1,249.83
1,076.33
Trade Payables
2,368.60
1,915.60
1,631.80
1,160.00
908.80
713.10
606.02
501.19
550.19
419.14
Other Current Liabilities
1,425.90
684.80
472.10
382.40
807.80
640.80
501.70
295.59
446.16
439.91
Short Term Borrowings
725.30
609.10
208.50
385.90
497.50
498.20
379.17
70.69
182.93
85.74
Short Term Provisions
144.70
115.40
121.90
109.70
123.20
103.30
80.33
95.89
70.55
131.54
Total Liabilities
18,793.90
16,081.70
14,579.30
12,430.50
12,289.80
10,037.40
9,374.35
8,799.79
7,359.80
6,459.16
Net Block
9,660.50
8,515.70
8,290.90
6,773.00
7,426.20
4,975.10
4,765.71
4,583.29
3,997.42
3,244.12
Gross Block
14,193.30
12,473.20
11,717.50
9,612.40
10,222.00
6,599.50
6,023.63
5,499.02
4,609.14
4,285.44
Accumulated Depreciation
4,532.80
3,957.50
3,426.60
2,839.40
2,795.80
1,624.40
1,257.92
915.73
611.73
1,041.32
Non Current Assets
13,514.20
11,744.70
10,518.70
8,789.00
9,643.00
7,755.60
7,154.22
6,670.57
5,385.23
4,520.29
Capital Work in Progress
872.80
609.90
45.50
233.90
235.60
821.80
712.20
346.86
561.56
532.64
Non Current Investment
302.10
281.40
314.80
350.20
365.10
399.30
301.26
307.96
270.65
165.08
Long Term Loans & Adv.
2,608.90
2,178.80
1,769.30
1,421.30
1,598.40
1,431.60
1,254.62
1,325.53
498.28
578.45
Other Non Current Assets
66.50
154.80
93.50
10.60
17.70
127.80
120.43
106.93
57.33
0.00
Current Assets
5,279.70
4,337.00
4,060.60
3,641.50
2,646.80
2,281.80
2,220.13
2,129.22
1,974.57
1,938.88
Current Investments
684.00
292.20
501.30
997.80
74.90
68.80
57.87
105.84
81.73
145.57
Inventories
459.80
390.10
431.90
249.50
737.80
584.70
565.84
466.87
406.13
350.26
Sundry Debtors
2,514.90
2,234.20
1,764.70
1,331.10
1,027.20
1,023.20
825.19
750.53
609.37
609.27
Cash & Bank
933.80
775.80
924.00
724.40
466.80
346.90
417.25
524.50
378.79
377.33
Other Current Assets
687.20
226.40
141.00
144.80
340.10
258.20
353.97
281.47
498.55
456.43
Short Term Loans & Adv.
429.00
418.30
297.70
193.90
96.70
79.40
112.29
223.03
437.25
419.99
Net Current Assets
615.20
1,012.10
1,626.30
1,603.50
309.50
326.40
652.90
1,165.86
724.74
862.55
Total Assets
18,793.90
16,081.70
14,579.30
12,430.50
12,289.80
10,037.40
9,374.35
8,799.79
7,359.80
6,459.17

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
1,920.20
1,376.90
1,696.00
1,264.50
1,292.90
905.20
536.96
622.55
597.17
469.95
PBT
1,380.50
1,100.50
1,578.10
221.50
656.90
373.60
59.56
131.12
305.25
455.41
Adjustment
1,199.20
1,108.40
681.40
1,079.80
1,012.50
770.10
807.85
703.53
425.00
274.83
Changes in Working Capital
-192.80
-450.00
-359.20
-72.10
-70.40
-46.00
-205.35
-78.48
10.82
-160.83
Cash after chg. in Working capital
2,386.90
1,758.90
1,900.30
1,229.20
1,599.00
1,097.70
662.06
756.17
741.07
569.42
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-466.70
-382.00
-204.30
35.30
-306.10
-192.50
-125.10
-133.62
-141.19
-100.28
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-2.71
0.81
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-1,537.20
-870.60
-847.20
-863.40
-288.80
-710.60
-404.91
-1,151.88
-888.21
-759.07
Net Fixed Assets
-1,399.90
-324.10
-166.80
1,127.70
-2,378.60
-622.09
-796.57
-582.72
-278.38
-570.07
Net Investments
-404.00
-158.10
31.60
-1,014.40
9.00
-185.02
163.48
-186.58
-164.16
-22.99
Others
266.70
-388.40
-712.00
-976.70
2,080.80
96.51
228.18
-382.58
-445.67
-166.01
Cash from Financing Activity
-311.10
-633.00
-791.60
-340.10
-909.60
-214.70
-108.50
476.95
329.93
392.31
Net Cash Inflow / Outflow
71.90
-126.70
57.20
61.00
94.50
-20.10
23.55
-52.37
38.89
103.19
Opening Cash & Equivalents
433.50
546.30
388.70
380.70
286.20
306.30
282.78
335.15
339.90
274.15
Closing Cash & Equivalent
505.50
433.40
546.50
425.20
380.70
286.20
306.33
282.78
378.79
377.33

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
469.76
424.53
389.89
319.08
239.10
238.71
233.02
237.25
238.81
227.87
ROA
5.26%
5.79%
8.15%
1.10%
3.90%
2.05%
0.65%
1.10%
3.01%
5.51%
ROE
14.26%
15.16%
21.60%
3.44%
13.08%
6.07%
1.81%
2.68%
6.41%
10.59%
ROCE
19.08%
17.78%
24.92%
9.32%
17.13%
10.24%
7.12%
6.94%
8.57%
12.09%
Fixed Asset Turnover
1.43
1.37
1.37
1.06
1.34
1.52
1.43
1.44
1.40
1.32
Receivable days
45.47
43.93
38.53
40.76
33.27
35.08
34.88
34.21
35.79
39.79
Inventory Days
8.14
9.03
8.48
17.06
21.46
21.83
22.86
21.96
22.21
22.16
Payable days
79.74
75.50
67.27
66.42
34.00
33.10
31.52
33.88
36.38
31.48
Cash Conversion Cycle
-26.12
-22.54
-20.26
-8.60
20.73
23.81
26.22
22.28
21.62
30.47
Total Debt/Equity
0.47
0.44
0.47
0.62
1.08
1.10
1.06
0.95
0.85
0.63
Interest Cover
4.03
4.00
5.17
1.49
2.24
2.14
1.58
1.70
2.69
4.86

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Apollo Hospitals Enterprise reports 49% jump in Q3 consolidated net profit
    11th Feb 2025, 15:41 PM

    Total consolidated income of the company increased by 14.60% at Rs 5590.70 crore for Q3FY25

    Read More
  • Apollo Hospital Ent. - Quarterly Results
    10th Feb 2025, 19:24 PM

    Read More
  • Apollo Hospitals Enterprise’s JV launches heart valve clinic
    4th Feb 2025, 11:39 AM

    The clinic offers a range of services, including advanced imaging, minimally invasive procedures, and traditional surgical options

    Read More
  • Apollo Hospitals Enterprise signs MoU with Mayapada Healthcare Group
    27th Jan 2025, 12:11 PM

    The city-based healthcare provider will offer its operational services to Mayapada Healthcare's upcoming hospital in Batam, Indonesia

    Read More
  • Apollo Hospitals Enterprise’s arm to acquire business from Searchlight Health
    26th Dec 2024, 14:12 PM

    The Business Transfer and execution of the BTA has been approved by the respective audit committees, board of directors and the shareholders of AHL and SHPL

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.